Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Malignant pleural mesothelioma (MPM) is an aggressive tumour associated with poor prognosis and limited treatment options, motivating the investigation of novel therapeutic approaches. Among these, chimeric antigen receptor (CAR)–based adoptive cell therapy has attracted considerable interest given its potential to achieve durable clinical responses.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
